Free tool
FAERS Monitor: Potassium Chloride 5meq In Dextrose 5% and Sodium Chloride 0.45% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018362 or its brand name (Potassium Chloride 5meq In Dextrose 5% and Sodium Chloride 0.45% In Plastic Container, Dextrose, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
11
Serious
4
36% of reports
Hospitalization
3
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood potassium increased2
- physical product label issue2
- product label confusion2
- product label issue2
- product packaging confusion2
- atrial fibrillation1
- atrial flutter1
- bradycardia1
- cardiac arrest1
- flushing1
- incorrect product storage1
- infusion related reaction1
- product barcode issue1
- product name confusion1
- product quality issue1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 3 |
| 2022 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,148 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product barcode issue | 1 | 4971.5 | 765.1 | 1,239 |
| physical product label issue | 2 | 3222.2 | 918.7 | 3,616 |
| product name confusion | 1 | 1756.0 | 270.7 | 438 |
| product packaging confusion | 2 | 1576.6 | 449.8 | 1,769 |
| product label confusion | 2 | 656.4 | 187.3 | 735 |
| product label issue | 2 | 563.9 | 160.9 | 631 |
| atrial flutter | 1 | 239.6 | 37.0 | 59 |
| blood potassium increased | 2 | 235.7 | 67.3 | 262 |
| incorrect product storage | 1 | 145.5 | 22.5 | 35 |
| bradycardia | 1 | 36.1 | 5.6 | 8 |
| infusion related reaction | 1 | 28.8 | 4.5 | 6 |
| cardiac arrest | 1 | 23.2 | 3.6 | 5 |
| atrial fibrillation | 1 | 19.6 | 3.0 | 4 |
| flushing | 1 | 18.8 | 2.9 | 4 |
| product quality issue | 1 | 14.1 | 2.2 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.